The Scientific Advisory Board (SAB) of the EPA announced a draft report critical of some of the Agency’s proposed changes to its cost-benefit analysis procedures under its Clean Air Act (CAA) program.
The EPA has announced that its Science Advisory Board (SAB) will significantly ramp up its research into the human and environmental health impacts of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19.
Concerns about instructions in a draft memorandum from EPA Administrator Andrew Wheeler about which proposed documents the Agency’s Science Advisory Board (SAB) reviews were raised in a letter Rep. Eddie Bernice Johnson (TX-D) sent to Wheeler. According to Johnson, the draft memo directed that the chair of the SAB, “in consultation with EPA,” would determine […]
In draft letters dated October 16, 2019, and addressed to EPA Administrator Andrew Wheeler, the chair of the Agency’s Science Advisory Board (SAB) raised substantive concerns about four major EPA regulatory proposals.